{"data":[{"accessionNo":"0001193805-26-001082","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Deerfield Management Company, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5006104,"percentOfClass":2.88,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001193805-26-001082","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Deerfield Mgmt, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5006104,"percentOfClass":2.88,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001193805-26-001082","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Deerfield Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5006104,"percentOfClass":2.88,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001193805-26-001082","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"James E. Flynn","reportingCik":null,"personType":"IN","sharesOwned":5006104,"percentOfClass":2.88,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0002100119-26-001323","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001622229","issuerName":"Cogent Biosciences Inc","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":8691589,"percentOfClass":5.08,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0002012383-26-002235","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":13593063,"percentOfClass":8,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001193805-26-000609","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"James E. Flynn","reportingCik":null,"personType":"IN","sharesOwned":9043903,"percentOfClass":5.29,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001193805-26-000609","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Deerfield Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":9043903,"percentOfClass":5.29,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001193805-26-000609","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Deerfield Management Company, L.P.","reportingCik":null,"personType":"PN","sharesOwned":9043903,"percentOfClass":5.29,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001193805-26-000609","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Deerfield Mgmt, L.P.","reportingCik":null,"personType":"PN","sharesOwned":9043903,"percentOfClass":5.29,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001104659-26-038056","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Fairmount Healthcare Fund II GP LLC","reportingCik":"0001830382","personType":"OO","sharesOwned":15356918,"percentOfClass":8.6,"filedAt":"2026-03-31","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001104659-26-038056","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Fairmount Funds Management LLC","reportingCik":"0001802528","personType":"IA","sharesOwned":15356918,"percentOfClass":8.6,"filedAt":"2026-03-31","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0000102909-26-000905","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences Inc","ticker":"COGT","cusip":"19240Q201","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001907884-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-31","reportingPerson":"Kynam Capital Management, LP","reportingCik":null,"personType":"IA","sharesOwned":6165223,"percentOfClass":4.33,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001907884-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-31","reportingPerson":"Kynam Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":6165223,"percentOfClass":4.33,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001907884-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-12-31","reportingPerson":"Yue Tang","reportingCik":null,"personType":"IN","sharesOwned":6165223,"percentOfClass":4.33,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001831942-26-000011","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"HC,IN","sharesOwned":2802905,"percentOfClass":1.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001831942-26-000011","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2802905,"percentOfClass":1.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001831942-26-000011","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":2802905,"percentOfClass":1.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001831942-26-000011","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":2802905,"percentOfClass":1.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0000102909-26-000056","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences Inc","ticker":"COGT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":11514326,"percentOfClass":7.5,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001104659-26-005917","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-01-22","reportingPerson":"Fairmount Healthcare Fund II GP LLC","reportingCik":"0001830382","personType":"OO","sharesOwned":16261918,"percentOfClass":9.9,"filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001104659-26-005917","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-01-22","reportingPerson":"Fairmount Funds Management LLC","reportingCik":"0001802528","personType":"IA","sharesOwned":16261918,"percentOfClass":9.9,"filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0002012383-26-000657","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":11370224,"percentOfClass":6.5,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0002012383-26-000802","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":11370224,"percentOfClass":6.5,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001104659-25-113219","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-13","reportingPerson":"Fairmount Funds Management LLC","reportingCik":"0001802528","personType":"IA","sharesOwned":15877418,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001104659-25-113219","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-13","reportingPerson":"Fairmount Healthcare Fund II GP LLC","reportingCik":"0001830382","personType":"OO","sharesOwned":15877418,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001831942-25-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-09-30","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":10208060,"percentOfClass":7.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001831942-25-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-09-30","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"HC,IN","sharesOwned":10208060,"percentOfClass":7.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001831942-25-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-09-30","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":10208060,"percentOfClass":7.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001831942-25-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-09-30","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":10208060,"percentOfClass":7.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001907884-25-000004","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-09-30","reportingPerson":"Yue Tang","reportingCik":null,"personType":"IN","sharesOwned":7886172,"percentOfClass":5.54,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001907884-25-000004","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-09-30","reportingPerson":"Kynam Capital Management, LP","reportingCik":null,"personType":"IA","sharesOwned":7886172,"percentOfClass":5.54,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001907884-25-000004","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001","eventDate":"2025-09-30","reportingPerson":"Kynam Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":7886172,"percentOfClass":5.54,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001193125-25-283076","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TCG Crossover GP I, LLC","reportingCik":null,"personType":"OO","sharesOwned":6798162,"percentOfClass":4.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001193125-25-283076","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TCG Crossover Fund I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6798162,"percentOfClass":4.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001193125-25-283076","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":6798162,"percentOfClass":4.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0000902664-25-005033","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":5753833,"percentOfClass":4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0000902664-25-005033","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":5753833,"percentOfClass":4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0000902664-25-005033","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5753833,"percentOfClass":4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001104659-25-112634","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":3156398,"percentOfClass":2.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001104659-25-112634","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":3156398,"percentOfClass":2.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001104659-25-112634","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3156398,"percentOfClass":2.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"},{"accessionNo":"0001104659-25-112634","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001622229","issuerName":"Cogent Biosciences, Inc.","ticker":"COGT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":2786647,"percentOfClass":2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cogt"}],"updatedAt":"2026-11-04T03:26:09.065Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/cogt","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}